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Two-color immunofluorescence studies  with  the  fluorescence-activated cell 
sorter (FACS) 1 distinguish three populations of mouse B cells according to the 
amounts of surface IgM and IgD expressed per cell (1-3). Characteristic strain 
and organ distributions  further define these populations.  Thus, a  population, 
termed  I,  that  expresses  high  IgD  and  intermediate  IgM  levels  is  the  most 
numerous in  most mice but  is  missing in  mice carrying the CBA/N  X-linked 
immunodeficiency. A population, termed II, that expresses high IgD and high 
IgM levels is found in comparable frequencies in all strains; and a population, 
termed III, that expresses low IgD and high IgM levels is found in spleen but 
not in lymph nodes and occurs at higher frequencies in xid and autoimmune 
mice than in normal mice. These populations are diagrammed on the IgM, IgD 
staining plots in Fig. 3. 
Populations  I,  II,  and  III  differentially express a  series of lymphocyte cell 
surface proteins including Ia, ThB and, very surprisingly, the pan-T cell antigen 
Ly-1  (2-4).  Ly-1, formerly called Lyt-1, is present on a  unique subpopulation 
(Ly-1  B) that comprises most of the cells in population  III (except in  CBA/N 
mice) and is greatly expanded in NZB-related autoimmune mice (3-5). Functional 
studies with sorted Ly-1  B cells show that these cells are solely responsible for 
the "spontaneous" IgM secretion peculiar to cultured NZB spleen cells (4).  IgM 
antibodies secreted in response to antigenic stimulation, in contrast, are produced 
by different spleen cells that carry neither Ly-1 nor IgD. 
The distinctive surface characteristics, functional properties, organ location, 
and development pattern demonstrated for Ly-1  B cells suggest that this small 
subpopulation (and consequently much of population III) represents a separate 
lineage of B cells (5).  The lineage relationships of the remaining B cells (which 
constitute  the  vast  majority  of the  Ig-bearing  cells),  however,  are  not  well 
understood. There are two major theories concerning the lineage distinctions 
among these cells (6,  7):  (a)  the single-lineage concept in  which a  pre-B  cell 
population proceeds through several stages of increasing "maturity" and termi- 
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nates in antibody-secreting cells (or memory cells);  and (b) the branched lineage 
concept in  which a  precursor  population  divides into  two (or more)  branches 
that have functionally distinct response properties. 
The argument for multiple B cell lineages is based on studies showing that the 
B cells responding to certain  types of antigens are distinguishable (8) and that, 
during  neonatal  development, responses to certain  antigens are  lower in com- 
parison  with  adults  (9).  In  addition,  work  with  CBA/N  mice,  which  fail  to 
respond  to a  subset of T-independent  (type 2) antigens  (10-12)  suggests that 
these mice lack a subset of B cells that express specific cell surface determinants 
(13-15)  known as Lyb-3,  Lyb-5, and  Lyb-7. These  mice clearly have fewer B 
cells and indeed are missing the majority type mature population found in normal 
mice defined by the correlated expression of IgM and IgD (1-3); however, the 
question remains as to whether this deficit represents a  maturationai  block in a 
single lineage or the complete deletion of a separate lineage.  More recent work 
(16,  17) with mice that have both xid and nude (nu/nu) defects has shown that 
the combined defect results in profound decreases in the serum levels of all Ig 
isotypes assayed and  in  the number of Ig-bearing cells in the lymphoid tissues 
(compared with either nude or xid mice). The data from these later studies were 
interpreted as favoring (but not proving) a branched lineage model (16,  17). 
In this study, we addressed this B cell lineage problem with the methods that 
we  had  used  to  define  and  characterize  the  Ly-1  B  population:  quantitative 
multiparameter analyses and sorting with fluorochrome-labeled monoclonal an- 
tibody reagents.  We first characterized  the reactivities of two monoclonal anti- 
bodies that label subpopulations of splenic B cells and then used correlated three- 
and  four-color  immunofluorescence  analyses  (18,  19)  with  these  and  other 
monoclonal  reagents  to  compare  normal,  xid,  and  nude  mouse  B  cells.  The 
results show that these monoclonal reagents recognize distinct antigens expressed 
on  functional  cell  populations,  consistent  with  the  suggestion  (16,  17) of two 
separate lineages of B cells (in addition to Ly- 1 B), one of which is missing in xid 
mice but not in nude animals and the other which is diminished in nude animals 
but not in xid mice. 
Materials and Methods 
Mice.  CBA/H-T6 and CBA/N, provided by Dr. J. J. Haaijman,  Institute of Experi- 
mental  Gerontology, TNO, The Netherlands, were bred at our animal facilities. BALB/ 
c mice were also bred in our facility. CBA nu]nu mice were generously provided by Dr. 
H. Wortis,  Tufts  University,  Boston,  MA and  Dr.  I.  L.  Weissman,  Stanford  Medical 
School, Stanford, CA. 
Monoclonal Antibodies.  Rat anti-mouse  IgM (clone 331-12) was produced by Dr. P. W. 
Kincade  (20).  Mouse monoclonal  anti-IgD  (specific for the a allotype,  Igh-5a)  and rat 
monoclonal antibodies 30-E2 and 53-10.1 were all produced and characterized in this lab 
(21, 22). 
Fluorochrome Coupling.  Biotin (Bi) and fluorescein  (FI) labeling procedures have been 
described elsewhere (23, 24). Reagents were conjugated at low (<3) label/protein ratios 
to minimize background staining.  Texas Red (TR)-labeled  avidin and peanut agglutinin 
(PNA) were prepared as described previously  (4) using  sulfarhodamine obtained from 
Molecular  Probes Inc., Junction City, OR. All reagents were stored at 4°C with  0.1% 
sodium azide and were deaggregated at  100,000 g for  10 min in a  Beckman  Airfuge 
(Beckman Instruments, Inc., Fullerton, CA) immediately  before use. 
Phycobiliprotein Conjugates.  We have previously  purified to homogeneity R-phycoery- HARDY ET AL.  1 171 
thrin (PE) and allophycocyanin (AP) from red algae by ammonium sulfate precipitation 
and chromatography on hydroxylapatite, followed by chromatography on an ACA-34 
(LKB, Bromma, Sweden) gel filtration column (25). The PE-avidin conjugate was prepared 
by cross-linking the two proteins with N-succinimidyi 3-(2-pyridyldithio)propionate  (SPDP) 
(26) and was generously provided by  John Kimura, Becton-Dickinson Monoclonal Center, 
Mountain View, CA. Phycobiliprotein antibody conjugates were prepared by labeling Ig 
with  succinimidyl-4-(N-maleimidophenyl)butyrate (SMPB)  (27)  and  then  reacting  this 
labeled protein with phycobiliprotein that had been previously thiolated with S-iminothio- 
lane (28). SPDP, SMPB, and S-iminothiolane were all purchased from Pierce Chemical 
Co., Rockford, IL. Molecular weight analysis by high performance liquid chromatography 
(HPLC)  (TSK-250  column;  Bio-Rad  Laboratories,  Richmond,  CA)  showed  that  the 
conjugates consist primarily of one or two dye proteins coupled to a single IgG. 
Tissue Section Staining.  Brachial  lymph  nodes  from  BALB/c  mice  immunized  with 
sheep erythrocytes (SE) were removed 7 d after footpad immunization with  10 million 
erythrocytes. Sections were prepared and stained as described previously (29), either with 
Bi-PNA  or with  Bi-anti-BLA-1; second-step horseradish  peroxidase-conjugated avidin 
revealed the staining after visualization with diaminobenzidine. Tissue staining was carried 
out in the laboratory of Dr. E. Butcher. 
Staining for FACS Analysis and Sorting.  Single-cell suspensions (from which the eryth- 
rocytes had been lysed by 0.165 M ammonium chloride) were stained in microtiter wells 
as  described previously (4).  Green fluorescence was  derived from directly labeled  FI 
reagents while red  fluorescence was  obtained by using biotinated first-step antibodies 
followed by TR-labeled avidin in a second incubation. Propidium iodide (PI) was added 
(50 ~i at 1 ~g/ml per well) to label dead cells (30). Larger numbers of cells (for sorting) 
were stained in  15-ml conical centrifuge tubes. Staining for three-color immunofluores- 
cence was carried out similarly, except that AP-conjugated reagent was included with the 
fluoresceinated and biotinated reagents in the first step and PE-labeled avidin replaced 
TR-labeled avidin in  the second incubation.  Four-color staining was  carried out using 
direct phycobiliprotein conjugates (PE and AP) together with a  biotin-labeled reagent, 
followed by TR-avidin  second-step staining.  PI  was  omitted in  three- and  four-color 
staining. 
Two-Color Immunofluorescence.  All the immunofluorescence studies were carried out on 
an extensively modified dual-laser FACS (B-D FACS Systems, Sunnyvale, CA) equipped 
with logarithmic amplifiers (for the fluorescence channels) to measure light scatter (size) 
and the amounts of fluorochrome-labeled monoclonai reagents bound to individual cells 
(18). In addition, we use PI staining (measured with a third fluorescence detection system) 
to eliminate the few (PI-stained) dead cells that failed to be rejected by the normal scatter- 
gating method for excluding dead cells (30). We used a  VAX computer to collect and 
store individual measurements on 30,000 (live) cells as list mode data for later analysis 
using programs developed by Mr. W. Moore of this department. 
Three- and Four-Color Immunofluorescence.  As has been described previously (31), it is 
possible to use a plant dye protein (PE) to obtain good quality two-color immunofluores- 
cence from a single laser (at 488 nm) exciting the fluorescence of FI (detected at 525 nm) 
and PE (detected at 570 nm). Electronic compensation (32) for the small  overlap of FI 
fluorescence on the PE detector and PE fluorescence on the FI detector yields signals 
essentially identical to either reagent used alone. We have added extra beam splitters, two 
extra photomultiplier tube detectors, and special filters that now permit us to use the 
single-laser/two-color system in conjunction with a second laser (at 605 nm) that excites a 
second pair of immunofluorescence dyes, TR (detected at 620) and AP, a second plant- 
derived fluorescent protein (33) (measured at 645 nm). This system will be described in 
detail elsewhere.  ~ 
Data  Analysis.  Two-color staining data  are presented as  contour plots  that can be 
viewed as representations of three-dimensional surfaces in which the levels of green and 
red fluorescence per cell define the location of cells on a (64 x 64) grid and the frequency 
Parks, D.  R.,  R.  R.  Hardy,  and  L.  A.  Herzenberg.  Four-color immunofluorescence using 
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of cells at each location defines the elevation at that location. After interpolating and 
smoothing this surface, contour lines were drawn to represent equal step changes in the 
elevation (frequency). Three-color staining data was analyzed by taking %lices" of the 
histogram generated from one of the stains (for example BLA-1 ÷ cells) and examining 
the correlated expression of the two other markers (for example IgM and IgD) within 
this gated population. Such slices are displayed as two-color contour plots. Similarly, four- 
color staining data was analyzed by gating on a rectangular region of a two-color contour 
plot for any two immunofluorescences (for example BLA-1 ÷, 2 +) and then displaying the 
two-color contour plot of the other two immunofluorescences (for example IgM and IgD) 
within this region. 
Immunizations and Antibody Responses.  Donors were primed with 2 ×  10  v SE 4 d before 
sorting and assay.  Plaque-forming cell (PFC)  estimations were performed by the Cun- 
ningham method (34). 
In Vitro Cultures.  Cells were cultured in RPMI 1640 (Irvine Scientific, Santa Ana, CA) 
supplemented with 10% fetal calf serum and 5 ×  10  -5 M 2-mercaptoethanol (2-ME) at 
106 cells/ml in 1-ml multiwell plates. Lipopolysaccharide (LPS) was added to such cultures 
at 25 #g/ml and concanavalin A (Con A) was used at 2 #g/ml. Large numbers of blast 
cells were found in mitogen-treated cultures 2-4 d after stimulation. 
Tumor Lines.  B cell tumor lines previously characterized for surface marker expression 
(35) were generously provided by Dr. L. Lanier, Becton-Dickinson Monoclonal Center. 
Trypsinization.  Spleen cell suspensions prepared as described above were first incubated 
at 37°C for 10 rain in various concentrations of trypsin. The cells were then washed free 
of enzyme and stained as usual for two-color analysis. 
lmmunoprecipitation  and Analysis.  30-E2  is a  rat IgG2b antibody and 53-10.1  is a  rat 
IgG2~ antibody. Immunoprecipitations were carried out with staph A after a  standard 
protocol from biosynthetically  labeled tumor cell cultures (36). Cells (5 × 106) were labeled 
for 16 h with 1 mCi of [35S]methionine and then cell extracts were prepared, precleared, 
and precipitated with antibody-coated staph A. Immunoprecipitated material was then 
analyzed by two-dimensional polyacrylamide gel electrophoresis, the first dimension to 
separate according to charge and the second according to molecular weight (36). 
Results 
Monoclonal Antibodies 30-E2 and 53-10.1 Identify B Cell Subsets.  Among a panel 
of rat anti-mouse spleen cell monoclonal antibodies (2 I), only two were found to 
react with a  subpopulation of the B cells in spleen.  One of these,  30-E2,  dully 
stained  ~10-15%  of adult  BALB/c  splenic  lymphocytes and  was  essentially 
negative on lymph node lymphocytes from the same animal. This pattern held 
for  all  strains  tested  except  CBA/N  (xid),  where  ~25-30%  of  the  splenic 
lymphocytes stained and the mean staining intensity was two- to fivefold higher 
than that of the positively stained BALB/c cells (Table I). Blocking studies with 
a  monoclonal antibody (14G8) described by Kung et al. (37) that shows similar 
reactivity patterns  suggest that these  antibodies  recognize  identical or  closely 
related determinants. The second monoclonal antibody, 53-10.1,  stained ~ 15 % 
of splenic iymphocytes but only ~ 1% of lymph node lymphocytes from unim- 
munized BALB/c mice. This pattern holds for all strains tested, including CBA/ 
N  (Table  I).  We refer to the antigen recognized by 53-10.1  as BLA-1  (B cell 
lineage antigen) and the antigen recognized by 30-E2 as BLA-2. 
We  have  used  two-color  immunofluorescence to  study the  relationships  of 
BLA-1  and  BLA-2  with each other  and with IgM and  IgD.  As Fig.  1  shows, 
BLA-2  is principally on high-IgM cells that are heterogeneous with respect  to 
their IgD expression. Thus, BLA-2 is on the majority of cells that fall within our 
previously defined B cell populations II and III. BLA-l-bearing cells, in contrast, HARDY  ET  AL.  1173 
TABLE  I 
BLA-1 and BLA-2 Antigens Are Expressed on Subsets of  B Cells 
Percentage of spleen cells stained 
BALB/c  CBA  CBA/N 
IgM  +  50  40  28 
BLA-I÷/IgM  +  17  15  16 
BLA-2÷/IgM  +  10  15  25* 
Spleen cells from 3-mo-old mice were stained with FI-anti-IgM together 
with  either  Bi-anti-BLA-1  or  Bi-anti-BLA-2.  TR-avidin revealed the 
biotin reagent staining. The BLA-1  antigen is defined by the 53-10.1 
monoclonal antibody. BLA-2 antigen is defined by the 30-E2 antibody. 
In adult mice, typically 90-95% of the BLA-1 + or BLA-2  ÷ cells in spleen 
are IgM  + (B cells). 
* Level of staining two- to fivefold higher than for normals. 
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FIGURE  1.  30-E2 and 53-10.1  stain subsets of B  cells,  Cells were cosmined with Flqal~led 
30-E2  or 53-10.1  (2 l) and biotin-coupled anti-IgM (20) or anti-IgD (22); TR-labeled avidin 
was used as the second step to reveal the biotinated antibody. Our threshold for positive 
staining was ~1  U for both axes. 
are  heterogenous  for  both  IgM  and  IgD  expression  and  therefore  cannot  be 
delineated  in  terms  of  the  previously  defined  subpopulations.  This  complex 
staining pattern  led us to apply recently developed three- and four-color immu- 
nofluorescence techniques to resolve these populations. 
Further Characterization of BLA-1  and BLA-2: Similarities and Differences.  Early 1174  BLA-1  AND  BLA-2  LINEAGE  ANTIGENS 
on  we  discovered  a  number  of similarities  between  the  BLA-1  and  BLA-2 
antigens.  Besides  being  on  subpopulations  of B  cells,  both  determinants  are 
present on macrophages and erythrocytes, but are  never found on  T  cells in 
thymus, spleen,  lymph node, and  peripheral  blood  (data  not shown).  BLA-1, 
however, is on most B cell tumor lines, such as CH1, WEHI-5, and WEHI-259, 
while BLA-2  is on only a  few lines, such as CH1  and  WEHI-259  (L.  Lanier, 
unpublished observations and 35). Furthermore, the BLA-1 expressed on spleen 
cells is  very sensitive to trypsinization  (as  is  IgD),  while BLA-2  is completely 
unaffected by this enzyme (Fig. 2). Our analyses indicate expression on lympho- 
cytes,  since  erythrocytes  were  eliminated  from  samples  before  staining  and 
granular cells were gated out by scatter at  120 ° (at large angles granular cells 
scatter considerably more light than ]ymphocytes). 
Immunoprecipitation and two-dimensional gel electrophoresis studies chemi- 
cally distinguish these antigens (manuscript in preparation). BLA-1 is a single 53 
kD acidic polypeptide while BLA-2 is not precipitated from any biosynthetically 
labeled cell extract.  This inability to precipitate the molecule bound by 30-E2 
may  mean  that  30-E2  recognizes  a  non-protein  determinant  (for  example  a 
glycolipid) or, alternately, that the protein is not well labeled during our incu- 
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FIGURE 2.  BLA-I (A) and lgD (D) were both trypsin-sensitive while BLA-2 (O) was as trypsin- 
resistant as IgM (x).  2-mo-old BALB/c spleen cells were treated with indicated amounts of 
trypsin for  10 min at 37°C and then stained with Fl-anti-IgM and either Bi-anti-BLA-l, Bi- 
anti-BLA-2, or Bi-anti-IgD. TR-avidin revealed staining with the biotin reagent. The mean 
staining intensity of the positive cells was normalized (for each stain) to the level found on 
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TABLE  II 
Tissue Distribution of BLA-I and BLA-2 on B Cells: Bone Marrow B 
Cells Express Both Antigens While Most Lymph Node B Cells Express 
Neither 
Percent positive cells 
Peripheral  Lymph 
Bone  Spleen  blood 
marrow  lymphocyte  node 
IgM  ÷  5  50  20  20 
BLA-I+/IgM  +  5  17  3  1 
BLA-2+/IgM  +  5  11  1  0.5 
Cells were analyzed  as described in Fig. 1. All cell suspensions  are from 3- 
mo-old BALB/c mice. BLA-1 was expressed on many IgM- cells in bone 
marrow (typically  70-80%) while BLA-2 was found on fewer IgM- cells 
in bone marrow (typically  10-20%). 
bation period.  We are pursuing the biochemical characterization of the  30-E2 
determinant. Recently, we have obtained L cell transfectants that stably express 
either BLA-1  or  BLA-2 which  may aid in the biochemical characterization of 
these molecules.  3 Thus, although there are some similarities in the expression of 
these two antigens, they are clearly different molecular species. 
Tissue Distribution and Developmental Expression.  The changes in expression of 
the BLA-1  and BLA-2  antigens during B  cell  development suggest that their 
levels  of expression  on  B  cells  are  inversely  related  to  the  degree  of B  cell 
maturity (Table II). Analyses of B cells taken from spleen, lymph node, and bone 
marrow of adult mice show that BLA-1 and BLA-2 are both present on all IgM  ÷ 
cells  in  the  bone  marrow.  In  contrast,  many  IgM  ÷  cells  in  spleen  lack  these 
antigens and most IgM  + cells in lymph node lack them.  In addition, BLA-1  is 
present on a majority of bone marrow cells that lack IgM, and, since these cannot 
all be pre-B cells (38), it appears likely that this antigen is also expressed on cells 
of non-B lineages. BLA-2, although on fewer IgM- bone marrow cells, is still on 
a  greater number of cells than can be accounted for as pre-B. Thus, although 
neither antigens is  B  lineage  specific,  their  variation  in  expression  on  B  cells 
appears related to B  cell maturity. We have investigated this relationship here 
by eliminating IgM- cells from the analyses and also by eliminating granular cells 
(defined by scatter at large angles). 
Similar studies with spleen cells from young mice (Table III) support the idea 
that BLA-1 and BLA-2 are primarily expressed on immature or precursor B cell 
populations. Most of the IgM+,IgD  + and IgM+,IgD  -  B cells in spleen expressed 
both BLA-1 and BLA-2 at 2 wk of age. As the mouse matured, the frequency of 
BLA-1-  and  BLA-2-bearing  cells  among total  splenic  B  cells  decreased.  This 
decrease  appears  to  be  due  to  the  emergence  of B  cell  population  !  in  the 
weanling animal, since the frequency of population I  cells reached stable adult 
levels by 2-3 mo of age and the frequency of BLA-1 ÷ and BLA-2  ÷ cells reached 
a stable minimum at about the same time. 
Three-Color Immunofluorescence  Data Demonstrate  that Different Subpopulations  of 
3 Hsu, C., P. Kavathas,  and L. A. Herzenberg. Expression of cell surface antigens on mouse L cells 
transfected with DNA from nonexpressing  cells. Manuscript submitted for publication. 1176  BLA-1  AND  BLA-2  LINEAGE  ANTIGENS 
TABLE  III 
All Splenic B Cells  from Immature Animals Express BLA-1 and BLA-2 
Percent positive cells in BALB/c mice aged: 
2-5 d  14 d  28 d  56 d 
IgM  +  5  15  30  50 
BLA-I+/IgM  +  5  15  30  15 
BLA-2+/IgM  +  5  10  10  10 
BLA-1 is also expressed on many IgM- spleen cells in young animals. For 
example, 90% of spleen cells from 2-5-d-old animals are BLA-1 +. 
B Cells Are Missing from xid and Nude Mice.  Since these antigens are present on 
non-B cells, two-color analysis of the correlated expression of BLA-1 and BLA- 
2 on B cells was always obscured by the variable numbers of non-B cells expressing 
one or both antigens. Accordingly, we used three-color immunofluorescence to 
study the relationship of BLA-1 and BLA-2 on IgM  + cells. Direct comparison of 
the correlated expression of BLA-1 and BLA-2 for CBA, CBA nu/nu, and CBA/ 
N  on B cells (IgM  +) clarifies the changes in B cells resulting from the xid and 
nude defects. As is shown in Fig. 3, all four possible types of splenic B cells were 
found in CBA by three-color analysis: BLA-I+,2  + cells, BLA-I-,2- cells, BLA- 
1+,2 - cells, and BLA-I-,2 + cells. 
The frequencies of the four BLAB cell types in normal, xid, and nude mice 
are summarized in Table IV. The major difference found is between CBA and 
CBA/N: the latter lacked BLA-I÷,2  -  cells. A second distinction is that CBA/N 
mice had fewer of the BLA-I-,2- (double-negative) B cells that constitute the 
predominant mature population  in  normal  mice.  In contrast,  nude mice had 
fewer BLA-I-,2 + cells and had more of the double negative cells (than normals). 
A striking finding is the similarity in the three strains of mice in the IgM-staining 
histogram for each BLA-1,BLA-2 type. That is, the BLA-I-,2 ÷ B cells had high 
levels of surface IgM whereas the BLA-I-,2- B cells had lower levels. 
Four-Color Immunofluorescence  Data Provide Evidence that the Correlated Expression 
of BLA-1 and BLA-2 Delineates  Two Distinct  Lineages  of B Cells.  The similarity of 
IgM expression on particular BLA-1,BLA-2 cell types led us to investigate the 
correlated expression of IgM and IgD within these four kinds of B cells using 
four-color immunofluorescence measurements. Such analyses comparing normal, 
xid, and nude splenic B cells demonstrated striking similarities in the correlated 
expression of IgM and IgD among the B cells that are BLA-I-,2  + in all three 
animals (Fig. 4). In addition, the similarities and differences in the IgM,IgD plots 
for the four BLA-1 ,BLA-2 types suggest relationships among these four kinds of 
B cells. Specifically, the BLA-I-,2  + cells had a correlated expression of IgM and 
IgD similar to that of a portion of the BLA-I+,2  + cells, and the BLA-I-,2- cells 
had  a  correlated expression  of IgM  and IgD  similar to  the  BLA-I+,2  -  cells. 
These cells (BLA-I+,2  -) in  turn had a  correlated expression of IgM and IgD 
similar  to  a  portion  of the  BLA-I÷,2  +  cells.  These  similarities  in  IgM,IgD 
expression together with the differences observed in mice with genetic defects 
(xid and  athymic) are  consistent  with  there  being  two  B  cell  developmental 
pathways (lineages). 
BLA-1 and BLA-2 Are Expressed on Antigen-stimulated B Cells.  Thus far we have a
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TABLE  IV 
BLA-1 and BLA-2 Together Define Four Types of B Cells, One of 
Which Is Missing  from CBA/N and Another That Is Found at Lower 
Frequency in Nude Mice 
Percentage of splenic B (IgM  +) ceils 
CBA/N  CBA  CBA nu/nu 
BLA-I-,2-  30  45  66 
BLA-I-,2  +  51  25  9 
BLA-I+,2  -  1  14  13 
BLA-I÷,2  ÷  17  16  12 
All animals  were between 3 and 6 mo of age. All cells were gated on IgM  + 
cells since, for example, BLA-I-,2- cells in spleen included all the T cells 
if not so gated. The boundaries used for determining percentages of cells 
in the four populations are drawn on the BLA-1/BLA-2 plots in Fig.  2. 
Percentages  are  expressed out of total IgM-bearing cells, which are as 
follows: CBA/N, 30% of total spleen cells; CBA, 45%; CBA nu/nu, 80%. 
All values are averages of at least five determinations of different animals, 
with deviations typically 5-10%. 
described results obtained with animals that were not specifically immunized and 
that appeared generally healthy. We specifically immunized animals to investigate 
the changes in BLA-1 and BLA-2 expression on B cells that occur upon immu- 
nization. As we showed earlier, lymph node B cells were essentially negative for 
both markers. After immunization, ~5-15% of lymph node cells expressed both 
markers, and (as is shown in Fig. 5) we found that such cells also stained brightly 
for the germinal center B cell marker, PNA (28, 39). Serial sections of immunized 
lymph node tissue (Fig.  5) confirmed that BLA-1  staining delineates germinal 
centers (defined by PNA) in immunized lymph node. 
Since germinal center cells expressed both BLA-1 and BLA-2, we next inves- 
tigated the antibody-forming cells (derived from germinal center cells) for BLA- 
1,9  expression.  To  do  this,  we  sorted  spleen  cell  suspensions  obtained  from 
immunized animals into  BLA-negative and -positive  fractions and carried  out 
plaque assays on the sorted cells. As shown in Table V,  BLA-1 ÷ cells included 
both  IgM  and  IgG  PFC  whereas  BLA-2  +  cells  included  only the  IgM  PFC. 
Furthermore,  adoptive  transfer  memory assays showed  that  BLA-1 ÷  cells  in- 
cluded memory cells 6  d after immunization, but did not include memory cells 
6 wk after immunization (data not shown). Thus, memory cells initially expressed 
BLA-1, but lost this marker soon after generation. 
Reexpression  of BLA-1  and BLA-2 on LPS Blast Cells.  To more carefully study 
the  appearance  of these  antigens  on  activated  cells,  we  analyzed spleen  cell 
cultures treated either with a B cell mitogen (LPS) or a T  cell mitogen (Con A). 
The data in Fig. 6 show that BLA-1 and BLA-2 expression was induced on LPS 
blasts (defined by forward scatter).  In addition, as is summarized in Table  VI, 
Con A  blasts expressed neither of these antigens. Thus, BLA-1 and BLA-2 are 
not  simply  "blast" antigens  that  appear  on  any dividing cell.  The  kinetics of 
appearance and disappearance of BLA-1 and BLA-2 are currently being inves- 
tigated more  thoroughly both in vitro and in  vivo.  FACS experiments clearly 
demonstrate that sorted BLA-1- cells cultured in the presence of LPS express BLA 
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FIGURE 4.  Four-color immunofluorescence revealed distinct IgM/lgD staining patterns for 
the four populations defined by the expression of BLA-1 and BLA-2. Cells were stained with 
Fl-anti-lgM, Bi-anti-IgD, PE-anti-BLA-2, and APoanti-BLA-I. TR-avidin revealed the IgD  ÷ 
cells.  The  plots  are  arranged  to  correspond  to  the  BLA-1/BLA-2 differentiation  model 
proposed in the Discussion and are diagrammed in Fig. 6: the "terminal" B cell populations 
for the two B cell lineages are at top (BLA-2 only) and bottom (BLA-I-,2-). 
both antigens  (data not shown).  In addition,  lymph node B cells (few of which 
expressed  either  BLA-1  or  BLA-2)  gave  rise  to large  numbers  of BLA-I+,2 + 
blasts when cultured for 4  d with LPS. Thus,  expression of BLA-1  and BLA-2 
can be induced on mature B cells that initially bear neither markers, by activating 
these cells either specifically with antigen or nonspecifically with the polyclonal 
B cell mitogen, LPS. o 
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FIGURE 5.  BLA-1 and BLA-2 were both expressed on germinal center cells. A cell suspension 
of immunized lymph node cells was incubated with TR-PNA together with either Fl-anti-BLA- 
1 or Fl-anti-BLA-2. Essentially all PNA-high cells were germinal center cells; such cells also 
stained for BLA-1  and BLA-2.  IgM PFC  (which are predominantly PNA-) also stained for 
BLA-I and BLA-2. Tissue section staining with BLA-1 clearly defined germinal centers in an 
immunized lymph node. Frozen serial sections of a lymph node taken from an SE-immunized 
BALB/c  mouse  were  stained  either  with  Bi-anti-BLA-1  (A)  or  Bi-PNA  (B)  followed  by 
horseradish peroxidase-conjugated avidin. Incubation with 0.1%  diaminobenzidine in 0.3% 
hydrogen peroxide in phosphate-buffered saline visualized the staining. 
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TAnLE  V 
IgM PFC Carry Both BLA-1 and BLA-2 While IgG PFC Carry only 
BLA-1 
1181 
igM PFC (1 o)  IgG PFC (2 °) 
Exp. 1  Exp. 2  Exp. 3  Exp. 4 
% 
BLA-I +  98  97  98  100 
BLA-1-  2  3  2  0 
BLA-2  +  I00  100  3  8 
BLA-2-  0  0  97  92 
The values reported are the percentages of antigen-specific PFC that fall 
within a particular range of BLA-1 or BLA-2 expression. Experiment  1 
(dinitrophenyl-keyhole  limpet  hemocyanin  [D-K]  immunization)  gave 
-1,000  IgM  PFC/spleen;  experiment  2  (trinitrophenyl-Ficoll)  gave 
~100,000  IgM PFC/spleen; experiment 3  (D-K, D-K) gave 70,000  IgG 
PFC/spleen; and experiment 4 (D-K, D-K) gave ~30,000 IgG PFC/spleen. 
IgM PFC in experiments 3 and 4 were both -500 PFC/spleen. Staining 
did not significantly alter the percentage of PFC per spleen. 
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FIGURE 6.  Expression of BLA-1 and BLA-2 was induced on LPS blasts.  Spleen cells were 
ltured with 25 ~g/ml LPS for 4 d and then stained with Bi-anti-IgM and Fl-anti-BLA-1 or F1- 
anti-BLA-2. TR-avidin was used to reveal the IgM staining. LPS blasts were defined by scatter. 
A small number of blasts were BLA-2-. The scatter profiles of BLA-1 and BLA-2 positive and 
negative cells in the LPS culture clearly demonstrate that the blast cells express both antigens. 1182  BLA-I  AND  BLA-2  LINEAGE  ANTIGENS 
TABLE  VI 
BLA-1 and BLA-2 Are Expressed on B Blasts But Not on T Blasts 
Percent positive cells after: 
LPS culture  Con A culture 
BLA-1 ÷  40*  1 
BLA-2  ÷  40*  <1 
IgM  ÷  70  15 
Thy-1 ÷  27  85* 
Spleen cells from 3-mo-old BALB/c mice were cultured for 2 d  either 
in 25 #g/ml LPS or 2 #g/ml Con A. 
* These fractions consist predominantly (>95%) of large (by scatter) cells. 
Discussion 
Data presented here comparing the correlated expression of BLA-1 and BLA- 
2 on CBA, CBA nu/nu, and CBA/N spleen cells demonstrate the existence of 
four types of B  (Ig  +) cells.  One of these lacked both  BLA-1  and  BLA-2  and 
included  the  predominant  recirculating  resting  B  cell  population  in  normal 
animals; the second expressed both antigens and appears to include B cells that 
migrated most recently from bone marrow to spleen (and have not as yet lost 
BLA-1 or BLA-2). The latter cell type (BLA-I+,2  +) was present in the spleens of 
all three strains of mice at similar levels, whereas the former (BLA-I-,2-) was 
found at considerably reduced frequency in CBA/N mice. 
Developmental expression and tissue distribution support the idea that BLA- 
1+,2 +  cells  in  the  spleen  include  the  most  immature  B  cells  (constituting  a 
"precursor" population) and that the BLA-1-,2- cells include the most mature B 
cells (constituting a  "terminal" population) that will rest as such unless they are 
stimulated with antigen.  That  is,  bone  marrow B  cells express both antigens, 
whereas few lymph node B cells (considered to be most "mature") express either 
antigen. Furthermore, all splenic B cells in the neonate express both BLA-1 and 
BLA-2, and the decrease in the percentage of B cells expressing these antigens 
coincides with the increase of population I (the mature resting B cells) that occurs 
between 1 and 2 mo of age. 
Two other BLA-1, BLA-2 B cell types were present in normal mouse spleen: 
one expressed BLA-1  but  lacked BLA-2 and the other expressed BLA-2  but 
lacked  BLA-1.  The  former  population  (BLA-I+,2  -)  was  greatly  diminished 
(tenfold or more) in xid mice while the latter (BLA-1-,2 +) was reduced (by two- 
to threefold) in athymic (nude) animals.  The decrease in both BLA-I+,2  -  and 
BLA-1-,2- cell types in xid mice and the similarity in the expression of IgM on 
both prompts us to suggest that the BLA-I+,2  -  cells represent cells that are in 
transition from the immature (precursor) BLA-I+,2  + stage to the mature (ter- 
minal) BLA-1-,2- resting B cell stage. The changes in frequency that occur in 
the  BLA-I+,2-/BLA-I-,2  -  types contrast with  the changes that  occur in  the 
BLA-I-,2 + cells. This is consistent with the concept of two distinct B cell lineages: 
xid mice possess the lineage that expresses BLA-2 alone, but lack the lineage 
that expresses BLA-1 alone (and derivative double negative cells), whereas nude 
mice have increased numbers of the lineage that expresses BLA-1  alone (and 
double negatives) and fewer cells of the lineage that express BLA-2 alone. HARDY ET  AL.  1183 
Four-color analysis permitted us to examine the correlated expression of IgM 
and  IgD  for  these  four  BLA-1,BLA-2  B  cell  populations,  and  such  analysis 
supports  the hypothesis that  these antigens distinguish separate lineages of B 
cells. The B cells that bear BLA-2 alone had a very different correlated expression 
of IgM and IgD compared with the B cells that bear neither BLA-1 nor BLA-2. 
Similarities and differences in the IgM,IgD expression on these four populations 
lead  us  to  propose  a  model  for  B  cell  differentiation in  the  spleen,  shown 
schematically in Fig. 7. Thus, we suggest that there are two "mature" populations 
of B cells in the spleen of normal mice, one that has neither BLA-1 nor BLA-2 
(and constitutes the majority of the recirculating B cell pool) and the other that 
has BLA-2 alone (residing mainly in the spleen). These correspond roughly to B 
cell  populations  I  and  II,  which  we  defined previously  on  the  basis  of the 
correlated levels of IgM and IgD. The lack of the BLA-I+,2  -  lineage (and its 
resulting BLA-I-,2- population) results in the aberrant IgM,IgD profile in xid 
mice that led us to initiate these studies. 
In  this  model  of B  cell  differentiation pathways,  we  show  the  BLA-I÷,2  + 
population as a single cell that branches to give two pathways. With four-color 
analysis, there is a suggestion of heterogeneity within this population: such cells 
from normal and nude mice have one population that expressed low IgM, high 
IgD levels and a second that expressed high IgM, low IgD levels; such cells from 
CBA/N mice have many fewer cells of the low IgM, high IgD phenotype (Fig. 
4). This suggests that the two lineages of B cells are distinct as early as the BLA- 
1  +,2 + stage, and that xid mice lack one lineage even at this stage of differentiation. 
Previous  studies  (16,  17)  have  suggested  that  xid  and  nude  animals  lack 
different lineages of B cells. CBA/N mice clearly have a deficit of the mature B 
cells found in normal animals and have a constellation of functional impairments 
associated with this defect, including a failure to respond to certain T-independ- 
ent (TI-2) antigens (10-12). Nude mice fail to respond to T-dependent antigens; 
however, it  is difficult to ascertain whether this  failure is due entirely to  the 
absence of T  cells that  control the further (antigen-driven) differentiation of 
FIGURE 7.  Model of B cell differentiation pathways showing expression  of IgM, IgD, BLA- 
1 (labeled  1) and BLA-2 (labeled  2). (+++) A high surface level of the particular antigen; (+ 
and +++) very heterogenous level of the particular antigen. 1184  BLA-1 AND BLA-2 LINEAGE ANTIGENS 
mature resting B cells or whether the immune defect in these mice also includes 
an impairment of B cell differentiation that results in an altered population of 
virgin B cells. 
A two-lineage model of B cell development has interesting implications, con- 
sidering the antigen response defects in nude and xid animals. Since xid mice do 
not  respond  to  TI-2  type antigens,  the  missing  lineage in  these  mice would 
appear to be required for response to such antigens. Previous studies (13-15) 
demonstrating that CBA/N mice lack Lyb-3+,5 + B cells suggest that the BLA- 
1+,2 -  B cells (and the mature BLA-I-,2- cells that derive from them) constitute 
this population.  Nude mice, in contrast, have fewer cells of a different putative 
lineage (BLA-I-,2 +) that may require either a  specific differentiating environ- 
ment (absent from nude mice) or direct stimulation from T  cells in order to 
appear. 
If we accept that the majority of the B cells in spleen and lymph nodes are 
derived from BLA-1 ÷,2 + cells (recently emigrated from bone marrow), then LPS 
clearly triggers BLA-1 and BLA-2 reexpression since (as we have shown) sorted 
BLA-1-  splenic  B  cells  cultured  with  LPS  give  rise  to  BLA-1 +  blast  cells. 
Furthermore, specific antigen stimulation apparently triggers a similar reexpres- 
sion (of BLA-1 and BLA-2) since germinal center cells are BLA-I+,2  ÷ and most 
likely are derived from the predominant B  cell population  (BLA-I-,2-) after 
immunization with  T-dependent antigens.  The  presence of both  BLA-1  and 
BLA-2 on IgM-secreting PFC also supports this hypothesis. 
The distinction that  BLA-2  makes between IgM- and IgG-secreting cells is 
striking and suggests that BLA-2 is lost as B cells differentiate further toward 
IgG secretion. Similarly, evidence that long-term resting memory B cells (6 wk 
after priming) do not express BLA-1 whereas the majority of short-term memory 
cells (5-7 d  after priming) do express BLA-1  indicates that antigen-stimulated 
BLA-1 expression can also be transient. Thus, these antigens may be gained and 
lost several times during B cell differentiation. 
These findings raise the question of whether BLA-1  and BLA-2 are B  cell 
blast antigens that appear on the cell whenever it leaves the resting stage (Go) of 
the  mitotic cycle and  are  lost  whenever it  returns  to  the  resting  state.  Our 
findings rule out this explanation in its simplest form since BLA-1  and BLA-2 
are expressed independently on individual cells and thus must be regulated by 
independently operating  mechanisms.  In  addition,  the  reexpression of these 
antigens does not simply represent the entry of resting (Go) cells into  mitosis 
since end-stage IgM-secreting cells (PFC) continue to express both antigens. 
Kung  et  al.  (37)  showed  that  a  monoclonal  antibody  called  14G8  (which 
apparently recognizes BLA-2) stains the majority of CBA/N  B cells, but  they 
concluded (rightly) that this antibody alone is  insufficient to  clearly resolve a 
lineage of B  cells  present  in  normal  mice but  missing  in  CBA/N.  Similarly, 
although the correlated expression of IgM and IgD defines a  population of B 
cells that is greatly diminished in CBA/N  mice (1-3), any attempt to precisely 
distinguish this population on the basis of IgM and IgD expression fails because 
the amounts of surface Ig on  the BLA-I-,2  + population  (present in  CBA/N) 
overlaps the amounts on the BLA-1 +,2- population (missing from CBA/N). 
In conclusion, BLA-1  and BLA-2 together divide B cells into several distinct HARDY ET AL.  1185 
functional subpopulations and probably define two distinct lineages of B  cells 
(one missing in CBA/N, the other depleted in nude mice). These populations/ 
lineages, which are both present in normal mice, roughly correspond to the so- 
called Lyb-3,5  ÷ and Lyb-3,5- B cell populations; however, we are wary of this 
notation since Lyb-3,5- cells are currently defined as the B cells present in CBA/ 
N mice and are not necessarily equivalent to any population of B cells in normal 
mice (40). 
Much work remains to correlate the expression of these B cell surface antigens 
with functionally defined B cell subpopulation properties (41),  to demonstrate 
the lineage relationships among these populations,  and to explain the genetic 
defects known for B cells. The findings to date, however, clearly demonstrate 
that caution is required in interpreting the results of functional studies conducted 
with unfractionated splenic B cells, even if such studies compare normal with xid 
B cells (42). In a sense, such studies are inadvisable since they could well be akin 
to studying T  cell function without recognizing the distinction between helper 
and suppressor subsets of T  cells. 
Summary 
Subpopulations of mouse B  cells express different amounts of two antigens 
(BLA-1 and BLA-2) recognized by rat monoclonal antibodies (53-10.1  and 30- 
E2). Two-color immunofluorescence analysis on the fluorescence-activated cell 
sorter (FACS) shows that the 53-10.1  monoclonal antibody reacts with a similar 
proportion of splenic B cells from normal and CBA/N (xid) mice, whereas 30- 
E2 reacts with most CBA/N B cells but with only a fraction of normal B cells. 
Data from three- and four-color immunofluorescence analyses with xid, athymic 
(nude), and normal mice suggest that the order in which these antigens are lost 
during B cell differentiation distinguishes two B cell lineages: immature B cells 
express both  antigens,  intermediate-stage B  cells of one or the other lineage 
express only BLA-1  or  only BLA-2,  respectively, and  mature resting B  cells 
express neither. CBA/N mice lack one of the putative intermediate populations 
(BLA-I+,2-);  thus,  this  population  apparently  gives  rise  to  the  predominant 
mature B cell population,  which is present in normal adult spleen and lymph 
node but  is  missing  in  CBA/N.  The  other  putative  intermediate population 
(BLA-I-,2  ÷) is decreased by two- to threefold in spleens from nude mice com- 
pared with strain-matched controls. 
Both BLA-1  and BLA-2 antigens rapidly reappear after specific (antigen) or 
nonspecific (lipopolysaccharide) B cell activation. IgM plaque-forming cells (PFC) 
derived from such activated cells continue to express both antigens while IgG 
PFC express only BLA-1. 
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